Mário Rui Abade

Dr. Mário Rui Abade

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Maria Deolinda AuxteroMaria Deolinda Auxtero
Maria Deolinda Auxtero
SCSusana Chalante
Susana Chalante
MAMário Rui Abade
Mário Rui Abade
Rui JorgeRui Jorge
Rui Jorge
Ana Isabel FernandesAna Isabel Fernandes
Ana Isabel Fernandes
Late-life mild cognitive impairment and dementia represent a significant burden on healthcare systems and a unique challenge to medicine due to the currently limited treatment options. Plant phytochemicals have been considered in alternative, or complementary, prevention and treatment strategies. Herbals are consumed as such, or as food supplements, whose consumption has recently increased. However, these products are not exempt from adverse effects and pharmacological interactions, presenting a special risk in aged, polymedicated individuals. Understanding pharmacokinetic and pharmacodynamic interactions is warranted to avoid undesirable adverse drug reactions, which may result in unwanted side-effects or therapeutic failure. The present study reviews the potential interactions between selected bioactive compounds (170) used by seniors for cognitive enhancement and representative drugs of 10 pharmacotherapeutic classes commonly prescribed to the middle-aged adults, often multimorbid and polymedicated, to anticipate and prevent risks arising from their co-administration. A literature review was conducted to identify mutual targets affected (inhibition/induction/substrate), the frequency of which was taken as a measure of potential interaction. Although a limited number of drugs were studied, from this work, interaction with other drugs affecting the same targets may be anticipated and prevented, constituting a valuable tool for healthcare professionals in clinical practice.

9 July 2021 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
Maria Deolinda AuxteroMaria Deolinda Auxtero
Maria Deolinda Auxtero
MAMário Rui Abade
Mário Rui Abade
SCSusana Chalante
Susana Chalante
BSBianca Silva
Bianca Silva
Ana Isabel FernandesAna Isabel Fernandes
Ana Isabel Fernandes
The use of nutraceuticals as cognitive enhancers is on the rise and may be especially problematic in polymedicated older patients. The potential of interaction of these products with drugs commonly prescribed to this age group is evaluated in this work, by identification of mutual targets (enzymes, transporters and receptors).